Atlas Trials

Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B Cell Lymphomas

Clinical trial NCT05133505 · COMPLETED

Trial details

NCT number
NCT05133505
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Study type
OBSERVATIONAL
Lymphoma, B-Cell
Start date
2002-01-01
Primary completion
2021-10-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.